Zydus Lifesciences received approval from the USFDA to market Ketoconazole Shampoo, an antifungal medication, in the US. This ...

This antifungal shampoo will be manufactured in Zydus Lifesciences’ topical manufacturing unit located at Changodar, ...

Zydus Lifesciences receives USFDA approval to market Ketoconazole Shampoo, a generic antifungal medication for dandruff, ...

Zydus Lifesciences Limited received final approval from the U.S. Food and Drug Administration (USFDA) to manufacture ...

Zydus Lifesciences has secured USFDA approval to market its generic Ketoconazole Shampoo for treating dandruff and fungal ...

Ketoconazole Shampoo is indicated for the treatment of dandruff, fungal infections and other skin conditions. It is an antifungal medication.

Ahmedabad: Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) ...

Zydus Lifesciences announced that it has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Ketoconazole Shampoo, 2% (USRLD: Nizoral Shampoo, 2%).

Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Ketoconazole Shampoo, 2% (USRLD: Nizoral Shampoo, 2%).

Zydus Lifesciences stock faces resistance at ₹920 and ₹940, with a downtrend likely to continue despite recent recovery.

Zydus Lifesciences Ltd on Wednesday (March 5) said it has received final approval from the United States Food and Drug ...

Zydus Lifesciences launches ANVIMO, a breakthrough drug for preventing Cytomegalovirus infection in transplant patients, ...